Publications & Presentations

Selected publications and presentations

Safety and efficacy of the CELT ACD femoral arteriotomy closure device in the office-based laboratory

Ahmed K. Ghamraoui, DO, MS,a Jake Forman, DO,a John Ricotta, MD, DFSVS, FACS,a,b and Joseph J. Ricotta II, MD, MS, DFSVS, FACS,a,b,c Boca Raton and Delray Beach, FL.

Significant Reduction In Pacu Costs With Use Of Celt ACD Compared To Other Closure Devices

Brandon Madris MD, Brittany Davis Keerthivasan Vengatesan, MD, Ronald Truong, MD, Litton Whitaker, MD, Amandeep Juneja MD, Alan M Dietzek, MD Danbury Hospital, Nuvance Health.

A Multicenter Randomized Trial Comparing the Effectiveness and Safety of a Novel Vascular Closure Device to Manual Compression in Anticoagulated Patients Undergoing Percutaneous Transfemoral Procedures: The CELT ACD^® Trial

Wong et al. Catheterization and Cardiovascular Interventions 90:756–765 (2017)

Short post-procedural bedrest using a vascular closure device in the femoral artery: Is it possible?

Jost, A. and Kouri, B., 2020. Short post-procedural bedrest using a vascular closure device in the femoral artery: Is it possible?. The Journal of Vascular Access, p.112972982091318.

Celt ACD, A Novel Stainless Steel Femoral Artery Closure Device, Reduces Time to Hemostasis, Patient Discomfort and Late Bruising Compared with Angio-seal™

Cahill, T., Malpass, F. and Kardos, A., 2014. 75 Celt ACD, A Novel Stainless Steel Femoral Artery Closure Device, Reduces Time to Hemostasis, Patient Discomfort and Late Bruising Compared with Angio-seal™. Heart, 100(Suppl 3), pp.A44.1-A44.

First Clinical Experience With Celt ACD: A Femoral Arterial Puncture Closure Device

Aftab Jan et al. 2013, Wiley Periodicals, Inc. DOI: 10.1111/joic.12046

Prospective Evaluation of the CELT Arterial Closure Device in an Outpatient Based Catheterization Laboratory

Presentation - Syed M Hussain MD. Charing Cross International Symposium, April 18 2019